Sonoma Pharmaceuticals Inc
(SNOA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 03-2020 | 03-2019 | 03-2018 | 03-2017 | 03-2016 | |
| Sales | 17,928 | 18,970 | 16,658 | 12,825 | 9,369 |
| Cost of Goods | 9,806 | 10,090 | 9,348 | 7,157 | 6,721 |
| Gross Profit | 8,122 | 8,880 | 7,310 | 5,668 | 2,648 |
| Operating Expenses | 16,318 | 20,228 | 21,847 | 18,799 | 18,083 |
| Operating Income | -7,390 | -11,258 | -14,189 | -12,974 | -14,714 |
| Interest Expense | 16 | 33 | 40 | 3 | 3 |
| Other Income | 3,862 | -49 | -49 | 40 | -7 |
| Pre-tax Income | -3,544 | -11,340 | -14,278 | -12,937 | -14,724 |
| Income Tax | 29 | 458 | 50 | -4,268 | N/A |
| Net Income Continuous | -3,573 | -11,798 | -14,328 | -8,669 | -14,724 |
| Net Income Discontinuous | 265 | N/A | N/A | 17,943 | 4,562 |
| Net Income | $-3,308 | $-11,798 | $-14,328 | $9,274 | $-10,162 |
| EPS Basic Total Ops | -44.80 | -255.40 | -569.80 | 396.04 | -556.26 |
| EPS Basic Continuous Ops | -48.40 | -255.37 | -569.70 | -369.04 | -806.48 |
| EPS Basic Discontinuous Ops | 3.60 | N/A | N/A | 765.08 | 250.23 |
| EPS Diluted Total Ops | -44.80 | -255.40 | -569.80 | 396.04 | -556.26 |
| EPS Diluted Continuous Ops | -48.40 | -255.37 | -569.70 | -369.04 | -806.48 |
| EPS Diluted Discontinuous Ops | 3.60 | N/A | N/A | 765.08 | 250.23 |
| EPS Diluted Before Non-Recurring Items | -78.00 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-7,078 | $-10,805 | $-13,699 | $-12,726 | $-14,470 |